SMPDL3A
SMPDL3A (sphingomyelin phosphodiesterase acid like 3A, also known as ASM3A or ASML3a) is a secreted cyclic-nucleotide phosphodiesterase. It degrades 2',3'-cGAMP and so acts as a negative regulator of innate immunity through the cGAS-STING pathway. Browse Assay Genie's current range of SMPDL3A research reagents below, or read on for the biology behind the target.
SMPDL3A is a cyclic-nucleotide phosphodiesterase that restrains innate immune signalling by breaking down 2',3'-cGAMP, thereby inhibiting the cGAS-STING pathway. It specifically linearises 2',3'-cGAMP into the 2'5'-bond product pGpA, and then hydrolyses pGpA further to give GpA. In vitro, the enzyme also shows nucleotide phosphodiesterase activity towards nucleoside triphosphates such as ATP, and has activity with p-nitrophenyl-TMP. Its activity is lower with nucleoside diphosphates, and it has none with nucleoside monophosphates.
The enzyme also acts in vitro on CDP-choline, producing CMP and phosphocholine, and on CDP-ethanolamine. Despite its name, SMPDL3A does not have sphingomyelin phosphodiesterase activity. It belongs to the acid sphingomyelinase family. NCBI Gene annotates it with phosphoric diester hydrolase and zinc ion binding activities, and with roles in negative regulation of the cGAS/STING signalling pathway and in nucleoside triphosphate catabolism. UniProt lists the protein as secreted, and it is located in extracellular exosomes.
The SMPDL3A gene is also known by the aliases FLJ20177, ASM3A, ASML3a and yR36GH4.1, and was previously named sphingomyelin phosphodiesterase acid-like 3A. Orthologues in mouse and rat are both named Smpdl3a. Because the protein works in the extracellular space on a second messenger that drives innate immune responses, it is a useful subject for studies of cGAMP turnover and cGAS-STING regulation.
SMPDL3A degrades 2',3'-cGAMP and inhibits cGAS-STING signalling, making it a point of control in this innate immune pathway.
The enzyme acts as a negative regulator of innate immunity, so it is studied to understand how immune activation is limited.
SMPDL3A hydrolyses nucleoside triphosphates such as ATP in vitro and takes part in nucleoside triphosphate catabolic processes.
The protein is secreted and is located in extracellular exosomes, which links it to studies of extracellular enzyme activity.
SMPDL3A is a secreted phosphodiesterase that degrades 2',3'-cGAMP. It linearises the molecule into pGpA and then hydrolyses this to GpA, which inhibits cGAS-STING signalling and negatively regulates innate immunity. It also hydrolyses nucleoside triphosphates such as ATP in vitro.
No. Although the name and the acid sphingomyelinase family membership suggest otherwise, UniProt states that SMPDL3A does not have sphingomyelin phosphodiesterase activity. Its characterised substrates include 2',3'-cGAMP, nucleoside triphosphates, CDP-choline and CDP-ethanolamine. Aliases include ASM3A and ASML3a.
Yes. Mouse and rat both have an orthologue named Smpdl3a. Researchers working in rodent models should check the datasheet of any product for its validated reactivity before choosing a reagent.
Other acid sphingomyelinase family members, cGAS-STING pathway proteins and nucleotide-metabolism enzymes with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q92484; product specifications from Assay Genie datasheets.